Luc-Mathieu FORNECKER

MD

ORCID – ResearcherID

(+33)

 

 

 

List of publications :

 

Tauty, A., Noblet, V., Paillard, C., Fornecker, L.-M., Namer, I. J., & Bund, C. (2019). Evaluation of the effects of chemotherapy on brain glucose metabolism in children with Hodgkin’s lymphoma. Annals of Nuclear Medicine, 33(8), 564–569. https://doi.org/10.1007/s12149-019-01363-8
Michallet, A.-S., Dilhuydy, M.-S., Subtil, F., Rouille, V., Mahe, B., Laribi, K., … Feugier, P. (2019). Obinutuzumab and ibrutinib induction therapy followed by a minimal residual disease-driven strategy in patients with chronic lymphocytic leukaemia (ICLL07 FILO): a single-arm, multicentre, phase 2 trial. The Lancet. Haematology. https://doi.org/10.1016/S2352-3026(19)30113-9
Quinquenel, A., Fornecker, L.-M., Letestu, R., Ysebaert, L., Fleury, C., Lazarian, G., … Baran-Marszak, F. (2019). Prevalence of BTK and PLCG2 mutations in a real‑life CLL cohort still on ibrutinib after three years: a FILO group study. Blood. https://doi.org/10.1182/blood.2019000854
Casasnovas, R.-O., Bouabdallah, R., Brice, P., Lazarovici, J., Ghesquieres, H., Stamatoullas, A., … Meignan, M. (2019). PET-guided, BEACOPPescalated therapy in advanced Hodgkin lymphoma - Authors’ reply. The Lancet. Oncology, 20(4), e190. https://doi.org/10.1016/S1470-2045(19)30156-1
Casasnovas, R.-O., Bouabdallah, R., Brice, P., Lazarovici, J., Ghesquieres, H., Stamatoullas, A., … Meignan, M. (2019). PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study. The Lancet. Oncology, 20(2), 202–215. https://doi.org/10.1016/S1470-2045(18)30784-8
Contejean, A., Resche-Rigon, M., Tamburini, J., Alcantara, M., Jardin, F., Lengliné, E., … de Fontbrune, F. S. (2019). Aplastic anemia in the elderly: a nationwide survey on behalf of the French Reference Center for Aplastic Anemia. Haematologica, 104(2), 256–262. https://doi.org/10.3324/haematol.2018.198440
Fornecker, L.-M., Muller, L., Bertrand, F., Paul, N., Pichot, A., Herbrecht, R., … Carapito, C. (2019). Multi-omics dataset to decipher the complexity of drug resistance in diffuse large B-cell lymphoma. Scientific Reports, 9(1), 895. https://doi.org/10.1038/s41598-018-37273-4
Schleiss, C., Ilias, W., Tahar, O., Güler, Y., Miguet, L., Mayeur-Rousse, C., … Vallat, L. (2019). BCR-associated factors driving chronic lymphocytic leukemia cells proliferation ex vivo. Scientific Reports, 9(1), 701. https://doi.org/10.1038/s41598-018-36853-8
Lescuyer, S., Ledoux, M.-P., Gravier, S., Natarajan-Amé, S., Duval, C., Maloisel, F., … Herbrecht, R. (2019). Tuberculosis and atypical mycobacterial infections in ruxolitinib-treated patients with primary or secondary myelofibrosis or polycythemia vera. International Journal of Infectious Diseases: IJID: Official Publication of the International Society for Infectious Diseases, 80, 134–136. https://doi.org/10.1016/j.ijid.2019.01.002
Gressin, R., Daguindau, N., Tempescul, A., Moreau, A., Carras, S., Tchernonog, E., … Lymphoma Study Association. (2019). A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma. Haematologica, 104(1), 138–146. https://doi.org/10.3324/haematol.2018.191429
Pigneux, A., Béné, M. C., Salmi, L.-R., Dumas, P.-Y., Delaunay, J., Bonmati, C., … French Innovative Leukemia Organization. (2018). Improved Survival by Adding Lomustine to Conventional Chemotherapy for Elderly Patients With AML Without Unfavorable Cytogenetics: Results of the LAM-SA 2007 FILO Trial. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 36(32), 3203–3210. https://doi.org/10.1200/JCO.2018.78.7366
Meyer, A., Fornecker, L.-M., Guffroy, A., Korganow, A.-S., & Martin, M. (2018). [Sinusoidal obstruction syndrome after BeAM conditioning regiment for autologous stem cell transplantation: Imputability of bendamustine? Report of two cases and literature review]. La Revue De Medecine Interne, 39(11), 882–885. https://doi.org/10.1016/j.revmed.2018.03.009
Chantepie, S. P., Garciaz, S., Tchernonog, E., Peyrade, F., Larcher, M.-V., Diouf, M., … Damaj, G. (2018). Bendamustine-based conditioning prior to autologous stem cell transplantation (ASCT): Results of a French multicenter study of 474 patients from LYmphoma Study Association (LYSA) centers. American Journal of Hematology, 93(6), 729–735. https://doi.org/10.1002/ajh.25077
Deau, B., Amorim, S., Perrot, A., Quittet, P., Cornillon, J., Chaoui, D., … Brice, P. (2018). Tandem haematopoietic stem cell transplantation for High Risk relapsed/refractory Hodgkin Lymphoma: a LYSA study. British Journal of Haematology, 181(3), 341–349. https://doi.org/10.1111/bjh.15184
Gauthier, J., Poiré, X., Gac, A.-C., Leclerc, M., Guillaume, T., Chalandon, Y., … Yakoub-Agha, I. (2018). Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin’s lymphoma undergoing allogeneic haematopoietic cell transplantation-a study by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy. Bone Marrow Transplantation, 53(4), 400–409. https://doi.org/10.1038/s41409-017-0018-z
Ittel, A., Gervais, C., Galoisy, A. C., M’Kacher, R., Mauvieux, L., & Fornecker, L. M. (2017). Triradial and quadriradial chromosomes detected in a case of B-cell prolymphocytic leukaemia. British Journal of Haematology, 179(5), 704. https://doi.org/10.1111/bjh.14895
Alhosin, M., León-González, A. J., Dandache, I., Lelay, A., Rashid, S. K., Kevers, C., … Schini-Kerth, V. B. (2015). Bilberry extract (Antho 50) selectively induces redox-sensitive caspase 3-related apoptosis in chronic lymphocytic leukemia cells by targeting the Bcl-2/Bad pathway. Scientific Reports, 5, 8996. https://doi.org/10.1038/srep08996
Miguet, L., Lennon, S., Baseggio, L., Traverse-Glehen, A., Berger, F., Perrusson, N., … Mauvieux, L. (2013). Cell-surface expression of the TLR homolog CD180 in circulating cells from splenic and nodal marginal zone lymphomas. Leukemia, 27(8), 1748–1750. https://doi.org/10.1038/leu.2013.3
Miguet, L., Béchade, G., Fornecker, L., Zink, E., Felden, C., Gervais, C., … Sanglier-Cianferani, S. (2009). Proteomic analysis of malignant B-cell derived microparticles reveals CD148 as a potentially useful antigenic biomarker for mantle cell lymphoma diagnosis. Journal of Proteome Research, 8(7), 3346–3354. https://doi.org/10.1021/pr801102c